- Home
- ATXI vs EVOK Comparison
ATXI vs EVOK Comparison
Compare ATXI & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXI
- EVOK
- Stock Information
- Founded
- ATXI 2015
- EVOK 2007
- Country
- ATXI United States
- EVOK United States
- Employees
- ATXI N/A
- EVOK N/A
- Industry
- ATXI Biotechnology: Pharmaceutical Preparations
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- ATXI Health Care
- EVOK Health Care
- Exchange
- ATXI Nasdaq
- EVOK Nasdaq
- Market Cap
- ATXI 2.9M
- EVOK 4.2M
- IPO Year
- ATXI 2017
- EVOK 2013
- Fundamental
- Price
- ATXI $1.99
- EVOK $5.34
- Analyst Decision
- ATXI Strong Buy
- EVOK
- Analyst Count
- ATXI 1
- EVOK 0
- Target Price
- ATXI $56.25
- EVOK N/A
- AVG Volume (30 Days)
- ATXI 32.2K
- EVOK 40.2K
- Earning Date
- ATXI 11-11-2024
- EVOK 11-07-2024
- Dividend Yield
- ATXI N/A
- EVOK N/A
- EPS Growth
- ATXI N/A
- EVOK N/A
- EPS
- ATXI N/A
- EVOK N/A
- Revenue
- ATXI N/A
- EVOK $7,525,709.00
- Revenue This Year
- ATXI N/A
- EVOK $124.10
- Revenue Next Year
- ATXI N/A
- EVOK $75.70
- P/E Ratio
- ATXI N/A
- EVOK N/A
- Revenue Growth
- ATXI N/A
- EVOK 110.79
- 52 Week Low
- ATXI $1.71
- EVOK $3.54
- 52 Week High
- ATXI $45.00
- EVOK $17.88
- Technical
- Relative Strength Index (RSI)
- ATXI 34.34
- EVOK 57.79
- Support Level
- ATXI $1.89
- EVOK $4.81
- Resistance Level
- ATXI $2.10
- EVOK $5.43
- Average True Range (ATR)
- ATXI 0.21
- EVOK 0.47
- MACD
- ATXI 0.00
- EVOK 0.01
- Stochastic Oscillator
- ATXI 33.33
- EVOK 55.46
About ATXI Avenue Therapeutics Inc.
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.